E. Schiff

Effectiveness of Simeprevir Plus Sofosbuvir, With or Without Ribavirin, in Real-World Patients With HCV Genotype 1 Infection

Mark Sulkowski, Hugo E. Vargas, Adrian M. Di Bisceglie et al. · Gastroenterology · 2015 · 179 citations · Full text

Pharmacy, Infectious Diseases, Pharmacotherapy +15

4 HCV SPRINT-1 FINAL RESULTS: SVR 24 FROM A PHASE 2 STUDY OF BOCEPREVIR PLUS PEGINTRON™ (PEGINTERFERON ALFA-2B)/RIBAVIRIN IN TREATMENT- NAIVE SUBJECTS WITH GENOTYPE-1 CHRONIC HEPATITIS C

Paul Y. Kwo, E. Läwitz, Jonathan McCone et al. · Journal of Hepatology · 2009 · 86 citations

Pharmacy, Infectious Diseases, Pharmacotherapy +17

LP14 : A phase 3, randomised, open-label study to evaluate the efficacy and safety of 8 and 12 weeks of simeprevir (SMV) plus sofosbuvir (SOF) in treatment-naïve and -experienced patients with chronic HCV genotype 1 infection without cirrhosis: Optimist-1

Paul Y. Kwo, Norman Gitlin, Ronald Nahass et al. · Journal of Hepatology · 2015 · 67 citations

Pharmacy, Infectious Diseases, Pharmacotherapy +14

Immediate and Late Outcome of Vaginal Myomectomy for Prolapsed Pedunculated Submucous Myoma

G Ben‐Baruch, E. Schiff, Y. Menashe et al. · Obstetrics and Gynecology · 1988 · 62 citations

Medicine, Gynecology, Surgery +14

Hepatitis C infection by polymerase chain reaction in alcoholics: false-positive ELISA results and the influence of infection on a clinical prognostic score.

Stephen H. Caldwell, Xuiming Li, R. Michael Rourk et al. · PubMed · 1993 · 61 citations

Medicine, Molecular Biology, Pathology +17